MR
Imaging of Stroke and Trauma: Neuroprotection Hall C |
M 892. NMR Imaging of the Neuroprotective Effects of Estrogen, J.D. Bui, J. Shi, D.L. Buckley, S.H. Yang, T.H. Lucas, M.A. King, A.L. Day, J.W. Simpkins and S.J. Blackband, University of Florida, Gainesville, FL, USA and National High Magnetic Field Laboratory, Tallahassee, FL, USA. |
T 893. Amlodipine, A Long Acting Dihydropyridine Calcium Antagonist, Reduces Cerebral and Renal Damage, in a Rat Model of Malignant Hypertension, E.L.A. Blezer, K. Nicolay, H.A. Koomans and J.A. Joles, University Hospital and Utrecht University, Utrecht, The Netherlands. |
W 894. Diffusion Weighted MRI Used to Assess if the Antioxidant U-101033E is Neuroprotective also in Case of Permanent Ischemia, M.H. Hjelstuen, A. Håberg and O. Haraldseth, SINTEF Unimed and University Hospital, Trondheim, Norway. |
Th 895. MRI Including Diffusion Weighted Imaging in the Evaluation of Neuroprotective Effects of Lubeluzole after Traumatic Brain Injury, R. Stroop, S.N. Kroppenstedt, J. Bernarding, K.J. Wolf, W. Lanksch and A. Unterberg, Humboldt-University of Berlin and Free University of Berlin, Berlin, Germany. |
M 896. Assessment of 2-Chloroadenosine Treatment after Experimental Traumatic Brain Injury in the Rat using Arterial Spin-Labeled MRI, C.L. Robertson, K.S. Hendrich, P.M. Kochanek, E.K. Jackson, J.A. Melick, S.H. Graham, D.W. Marion, D.S. Williams and C. Ho, University of Pittsburgh and Carnegie Mellon University, Pittsburgh, PA, USA. |
T 897. Assessment of Neurotoxicity in Rat Brain by Magnetic Resonance Microscopy, R.C. Lyon, D.S. Lester, J.N. Johannessen, G.N. McGregor, R.T. Engelhardt and G.A. Johnson, Food and Drug Administration, Laurel, MD, USA; NCI Frederick Biomedical Supercomputing Center, Frederick, MD, USA and Duke University Medical Center, Durham, NC, USA. |
W 898. Improved Behavioural Recovery Correlated with MRI and Morphology After SDZ EAA494 Treatment, A Novel NMDA Receptor Antagonist, Evaluated in Experimental Stroke Treatment, Z. Chen, A. Sauter and B. Bjelke, Karolinska Institutet, Stockholm, Sweden and Novartis Pharma, Basel, Switzerland. |
Th 899. Evaluation of rCBF in Excitotoxic Neuronal Injury Using FAIR Technique, C.S. Lee, Y.L. Pan and C. Chang, Academia Sinica, Taipei, Taiwan, ROC. |
M 900. 8.4T T2 and Diffusion Weighted MRI of Traumatic Brain Injury in Mice, O.M. Oreg, R. Duvdevani, A. Dimitrochenko, M. Hadani and Y. Cohen, Tel Aviv University, Tel Aviv, Israel; Israel Institute of Biological Research, Ness-Ziona, Israel and Sheba Medical Center, Tel-Hashomer, Israel. |
T 901. Diffusion-Weighted MRI Questions the 'Very Delayed' Development of Cerebral Infarction in Rats after 30 Minutes of Focal Ischaemia, E.S. Karnick, T. Christensen and N.H. Diemer, University of Copenhagen, Denmark. |